Interstitial Lung Disease Trial, Recruiting (NCT06122233)

Interstitial Lung Disease Trial, Recruiting NCT06122233 Sponsor: University of Sydney Condition: Interstitial Lung Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06122233 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Interstitial Lung Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with a fibrotic interstitial lung disease (a type of scarring lung condition) (confirm with trial site)
You own a smartphone or tablet and have an email address
You can read and speak English
You are comfortable enough with technology to complete the tasks required by the trial
You have been on a stable treatment for your lung condition for at least 30 days before joining the trial

Who may not be able to join:

You do not own a smartphone or tablet
You are not comfortable enough with technology to complete the tasks required by the trial
You are not able to communicate in written or spoken English
You have not been on a stable treatment for your lung condition for at least 30 days before joining the trial
You have had a sudden worsening of your lung condition in the 30 days before joining the trial
You are currently taking part in, or plan to take part in, a pulmonary rehabilitation programme (a breathing and exercise programme) during the 12-week trial period
You are not able to give your informed consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Tamera Corte, University of Sydney

Phone: +61 2 9515 5682

Australian sites

Royal Prince Alfred Hospital, Sydney, New South Wales
+61 2 9515 5682

The Prince Charles Hospital, Brisbane, Queensland
+61 7 3139 6298

Alfred Hospital, Melbourne, Victoria
+61 3 9076 3600

Austin Health, Melbourne, Victoria
+61 3 9496 3874

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06122233

Sponsor: University of Sydney

Phase: Not Applicable

Status: Recruiting

Condition: Interstitial Lung Disease

Trial contact: +61 2 9515 5682

More information: https://clinicaltrials.gov/study/NCT06122233

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with a fibrotic interstitial lung disease (a type of scarring lung condition) (confirm with trial site)
You own a smartphone or tablet and have an email address
You can read and speak English
You are comfortable enough with technology to complete the tasks required by the trial
You have been on a stable treatment for your lung condition for at least 30 days before joining the trial

Who may not be able to join:

You do not own a smartphone or tablet
You are not comfortable enough with technology to complete the tasks required by the trial
You are not able to communicate in written or spoken English
You have not been on a stable treatment for your lung condition for at least 30 days before joining the trial
You have had a sudden worsening of your lung condition in the 30 days before joining the trial
You are currently taking part in, or plan to take part in, a pulmonary rehabilitation programme (a breathing and exercise programme) during the 12-week trial period
You are not able to give your informed consent to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Sydney

Registry

ClinicalTrials.gov

Start date

3 June 2024

Est. completion

1 June 2027

Where this trial is recruiting

🇦🇺 Australia

4 site(s) in Australia. Confirm current status and contact details directly with the trial site.

Primary endpoints

Change in King's Brief Interstitial Lung Disease (K-BILD) questionnaire score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov